Optimizing Response to Li Treatment Through Personalized Evaluation of Individuals With Bipolar I Disorder: The R-LiNK Initiative

NCT04209140 · clinicaltrials.gov ↗

UNKNOWN

Status

320

Enrollment

OTHER

Sponsor class

Conditions

Bipolar I Disorder

Interventions

DRUG: lithium treatment

Sponsor

Assistance Publique - Hôpitaux de Paris